¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå
Remote Patient Monitoring Systems
»óǰÄÚµå : 1513897
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 442 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,260,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,780,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 91¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»ó

2023³â¿¡ 26¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 19.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 91¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠƯ¼ö ¸ð´ÏÅÍ´Â CAGR 18.9%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á ½Ã 72¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅÍ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 22.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 7¾ï 2,060¸¸ ´Þ·¯, Áß±¹Àº CAGR 18.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀº 2023³â 7¾ï 2,060¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 14¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ 2023-2030³âÀÇ CAGRÀº 18.6%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 17.0%¿Í 16.7%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 13.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) ½Ã½ºÅÛÀº ´ç´¢º´ ¹× °íÇ÷¾Ð°ú °°Àº ¸¸¼º Áúȯ °ü¸®¿¡ ÇʼöÀûÀÎ ¼­ºñ½º¸¦ Á¦°øÇϰí Äɾî Á¦°øÀ» °­È­ÇÏ´Â °Ç°­ °ü¸®¿¡¼­ Á¡Á¡ ´õ Áß¿ä ÇØÁö°í ÀÖ½À´Ï´Ù. Ç÷¾Ð°è, Ç÷´ç°è, ½º¸¶Æ® ¿öÄ¡¿Í °°Àº °í±Þ ¿þ¾î·¯ºí°ú °°Àº Ä¡·á Àåºñ¸¦ ÀÌ¿ëÇÏ´Â RPM ½Ã½ºÅÛÀº °Ç°­ µ¥ÀÌÅÍÀÇ Áö¼ÓÀûÀÎ ¼öÁýÀ» °¡´ÉÇÏ°Ô Çϰí, ÀÇ·á Á¦°ø¾÷ü´Â À̸¦ ÀÌ¿ëÇÏ¿© ȯÀÚ¸¦ ¸ð´ÏÅ͸µ ±×¸®°í ±×¿¡ µû¶ó Ä¡·á °èȹÀ» Á¶Á¤ÇÕ´Ï´Ù. ¼³¹®Á¶»ç´Â ÀÔ¿ø±â°£ÀÇ ´ÜÃà°ú Ä¡·áÀÇ Àû½Ã Á¶Á¤¿¡ ÀÇÇÑ ¸¸¼ºÁúȯ °ü¸® °³¼± µî RPMÀÇ ÀåÁ¡À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ÆÒµ¥¹Í(¼¼°èÀû À¯Çà)ÀÇ °æ¿ì RPMÀÌ ¿ø°ÝÁö¿¡¼­ ȯÀÚ¸¦ ¸ð´ÏÅ͸µÇÏ°í º´¿ø ºÎ´ãÀ» ÁÙÀÌ´Â µ¥ ¸Å¿ì Áß¿äÇÏ´Ù´Â °ÍÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù. ¶Ç, º´¿ø ·¹º§ÀÇ Ä¡·á¸¦ ÀçÅà ȯÀÚ¿¡°Ô Á¦°øÇÏ´Â °ÍÀ¸·Î, ±ä±Þ½ÃÀÇ ÁøÂûÀ̳ª ÀÔ¿øÀ» ÁÙÀÌ´Â ÀçÅÃÄ¡·á ÇÁ·Î±×·¥¿¡¼­µµ È¿°ú¸¦ ¹ßÈÖÇϰí ÀÖ½À´Ï´Ù.

RPMÀÇ ±ÔÁ¦ »óȲÀº ±Þ¼ÓÈ÷ ÁøÈ­Çϰí ÀÖÀ¸¸ç, ƯÈ÷ COVID-19 ÆÒµ¥¹Í ½Ã¿¡ ºÎ°¢µÈ ¿ä±¸°¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¸ÞµðÄÉ¾î ¸ÞµðÄÉÀÌµå ¼­ºñ½º¼¾ÅÍ(CMS)¿Í °°Àº ±â°üÀÌ RPM ÀÌ¿ëÀ» È®´ëÇϱâ À§ÇÑ »õ·Î¿î Á¤Ã¥°ú ¸éÁ¦Á¶Ä¡¸¦ µµÀÔÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº º¸´Ù ÀÌ¿ëÇϱ⠽¬¿öÁ® ´Ù¾çÇÑ ÇコÄɾî ȯ°æ¿¡ Àû¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¹Ì·¡¸¦ Àü¸ÁÇÒ ¶§, ÷´Ü ±â¼úÀÇ ÅëÇÕ°ú RPMÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡´Â À¯¸ÁÇÑ ¹Ì·¡¸¦ °¡¸®Åµ´Ï´Ù. ÀÌ´Â º¹ÀâÇÑ »ç·Ê¸¦ ¿ø°ÝÀ¸·Î °ü¸®Çϱâ À§ÇØ ÀÇ·á ½Ã½ºÅÛÀÌ RPMÀ» äÅÃÇÏ´Â °æ¿ì°¡ ´Ã¾î³ª°í Àֱ⠶§¹®¿¡ ºÐ¸íÇϸç, ¹°¸®Àû °Ç°­ °ü¸® ½Ã¼³¿¡ ´ëÇÑ ºÎ´ãÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü°ú Ãß°¡ ÀÚ±ÝÀº RPM ÀåºñÀÇ ±â´É°ú È¿À²¼ºÀ» Çâ»ó½Ã۰í, ¿ø°Ý ¸ð´ÏÅ͸µÀÌ Çö´ë °Ç°­ °ü¸® Á¦°øÀÇ ±âÃÊÀûÀÎ Ãø¸éÀÌ µÇµµ·Ï ÇÕ´Ï´Ù.

RPM ±â¼úÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿©·¯ °¡Áö ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ ºÐ¼®°ú AI ÅëÇÕÀÇ Çâ»óÀ¸·Î ȯÀÚ ¸ð´ÏÅ͸µÀÇ Á¤È®¼ºÀÌ Çâ»óµÇ°í ¿¹ÃøÀûÀÎ ÀÇ·á °³ÀÔÀÌ °¡´ÉÇÕ´Ï´Ù. 5G¿Í °°Àº ¿¬°á ¼Ö·ç¼ÇÀÇ °³¼±Àº RPM Àåºñ¿¡¼­ ÀÇ·á Á¦°ø¾÷ü·ÎÀÇ ½Å·ÚÇÒ ¼ö ÀÖ´Â µ¥ÀÌÅÍ Àü¼ÛÀ» º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ ¼ÒºñÀÚÀÇ °Ç°­ Àǽĵµ Å©°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç ½Ç½Ã°£ °Ç°­ ÁöÇ¥ Çǵå¹éÀ» Á¦°øÇÏ´Â °Ç°­ ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ±â¼úÀÇ Àαâ´Â Áö¼ÓÀûÀÎ °Ç°­ ÃßÀûÀ» Á¤»óÈ­Çϰí RPMÀÇ ¼ö¿ëÀ» ´õ¿í Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¸ÞµðÄɾî¿Í ¸ÞµðÄÉÀ̵带 Æ÷ÇÔÇÑ º¸Çè¾÷ÀÚÀÇ ÁöÁöÀûÀÎ ±ÔÁ¦ Ʋ°ú »óȯ Á¤Ã¥ÀÇ È®´ë·Î RPM ¼­ºñ½º´Â º¸´Ù ÀÌ¿ëÇϱ⠽±°í Àú·ÅÇÕ´Ï´Ù. ¶ÇÇÑ ¿ø°Ý Áø·á¿¡ ´ëÇÑ È¯ÀÚÀÇ ¿ä±¸¿Í ¾÷¹« È¿À²¼ºÀ» À§ÇØ RPMÀ» äÅÃÇÑ ÀÇ·á Á¦°ø¾÷üÀÇ ¿òÁ÷ÀÓÀº º¸´Ù ÅëÇÕµÈ ±â¼ú Áß½ÉÀÇ È¯ÀÚ Á᫐ ÀÇ·á ¼Ö·ç¼ÇÀ¸·ÎÀÇ º¯È­¸¦ ºÎ°¢½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀº Á¾ÇÕÀûÀ¸·Î RPM ½Ã½ºÅÛÀÇ µµÀÔ°ú È¿À²¼ºÀ» ³ôÀ̰í ÀÇ·á °ü¸® ±â¹ýÀÇ Áö¼ÓÀûÀÎ º¯È­¸¦ ¹Ý¿µÇÕ´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 162°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Remote Patient Monitoring Systems Market to Reach US$9.1 Billion by 2030

The global market for Remote Patient Monitoring Systems estimated at US$2.6 Billion in the year 2023, is expected to reach US$9.1 Billion by 2030, growing at a CAGR of 19.6% over the analysis period 2023-2030. Special Monitors, one of the segments analyzed in the report, is expected to record a 18.9% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the Vital Sign Monitors segment is estimated at 22.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$720.6 Million While China is Forecast to Grow at 18.6% CAGR

The Remote Patient Monitoring Systems market in the U.S. is estimated at US$720.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 18.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.0% and 16.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.8% CAGR.

Global Remote Patient Monitoring Systems Market - Key Trends and Drivers Summarized

Remote Patient Monitoring (RPM) systems are increasingly critical in healthcare, providing vital services for the management of chronic diseases like diabetes and hypertension and enhancing care delivery. Utilizing devices such as blood pressure monitors, blood glucose meters, and advanced wearables like smartwatches, RPM systems allow continuous collection of health data, which healthcare providers use to monitor patients and adjust treatment plans accordingly. Research has highlighted the benefits of RPM, including reducing hospital stay lengths and improving the management of chronic diseases by facilitating timely adjustments in treatment. Especially evident during the pandemic, RPM proved crucial for monitoring patients remotely, alleviating hospital burdens, and has been effective in hospital-at-home programs, which deliver hospital-level care to patients at home, thereby reducing emergency visits and hospitalizations.

The regulatory landscape for RPM has evolved rapidly, particularly spurred by the needs highlighted during the COVID-19 pandemic. Changes by entities like the Centers for Medicare and Medicaid Services (CMS), which introduced new policies and waivers to broaden RPM usage, have made these systems more accessible and applicable across various healthcare settings. Looking forward, the integration of advanced technologies and a growing recognition of the benefits of RPM point to a promising future. This is evidenced by the increasing adoption of RPM by health systems to manage complex cases remotely, thus reducing pressure on physical healthcare facilities. Continued advancements in technology and additional funding are enhancing the capabilities and efficiency of RPM devices, ensuring that remote monitoring remains a foundational aspect of modern healthcare delivery.

Several factors are driving the growth of RPM technology. Enhanced data analytics and AI integration improve patient monitoring accuracy, enabling predictive healthcare interventions. Improvements in connectivity solutions, such as 5G, ensure reliable data transmission from RPM devices to healthcare providers. There's also a significant increase in consumer health awareness, which has boosted demand for health monitoring devices providing real-time health metrics feedback. The popularity of wearable technologies has normalized continuous health tracking, further aiding RPM acceptance. Supportive regulatory frameworks and expanded reimbursement policies by insurance providers, including Medicare and Medicaid, are making RPM services more accessible and affordable. Additionally, patient demand for remote care options and healthcare providers' adoption of RPM for operational efficiency highlight the shift towards more integrated, technology-driven, and patient-centered healthcare solutions. These factors collectively enhance the adoption and effectiveness of RPM systems, reflecting an ongoing transformation in healthcare management practices.

Select Competitors (Total 162 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â